James Laird, MD

Laird J, Decker R, Roberts K, Park H. Radiation Pneumonitis. In: Grippi M, Antin-Ozerkis D, Dela Cruz C, Kotloff R, Kotton C, Pack A (editors). Fishman’s Pulmonary Diseases and Disorders, 6th edition. New York: McGraw-Hill: 2023; p. 966-986.

Crosby T, Laird J, Park H, McWharter A. Early Laryngeal Cancer. In: Johnson J and Rosen C (editors). Bailey’s Head & Neck Surgery Otolaryngology, 6th Edition. Philadelphia: LWW: 2022; Chapter 141.

Laird J, Leventhal J, Kanowitz J, Damast S. Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer. Practical Radiation Oncology 2021, 11: 448-452. PMID: 34157449, DOI: 10.1016/j.prro.2021.06.001.

Mokhtech M, Laird JH, Maroongroge S, Zhu D, Falit B, Johnstone PAS, Mantz CA, Ennis RD, Sandler HM, Dosoretz AP, Yu JB. Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties. International Journal Of Radiation Oncology • Biology • Physics 2021, 110: 322-327. PMID: 33412264, DOI: 10.1016/j.ijrobp.2020.12.051.

Laird J, Tymon-Rosario J, Damast S. Ovarian Cancer. 2020 DOI: 10.1891/9780826155146.0026.

Laird J, An Y, Damast S. Endometrial Cancer. 2020 DOI: 10.1891/9780826155146.0027.

Laird J, Young M, Damast S. Cervical Cancer. 2020 DOI: 10.1891/9780826155146.0028.

Laird J, Damast S. Vaginal Cancer. 2020 DOI: 10.1891/9780826155146.0029.

Laird J, Young M, Damast S. Vulvar Cancer. 2020 DOI: 10.1891/9780826155146.0030.

Laird J, Lok B, Carney B, Kossatz S, de Stanchina E, Reiner T, Poirier J, Rudin C. Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient–Derived Xenografts. Journal Of Thoracic Oncology 2019, 14: 1743-1752. PMID: 31195178, PMCID: PMC6764879, DOI: 10.1016/j.jtho.2019.05.032.

Ma J, Laird J, Chau K, Chelius M, Lok B, Yahalom J. Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies. Cancer Medicine 2018, 8: 58-66. PMID: 30597769, PMCID: PMC6346231, DOI: 10.1002/cam4.1844.

Laird J, Braunstein LZ. ASO Author Reflections: Breast Cancer Local Recurrence Versus New Primary-Clinical Predictors and Prognostic Implications. Ann Surg Oncol 2018, 25: 648-649. PMID: 30306376, DOI: 10.1245/s10434-018-6889-4.

Laird J, Braunstein LZ. Reply to "Questions About In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy". Ann Surg Oncol 2018, 25: 3779. PMID: 29270878, DOI: 10.1245/s10434-017-6286-4.

Laird J, Lok B, Ma J, Bell A, de Stanchina E, Poirier J, Rudin C. Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts. Clinical Cancer Research 2018, 24: 5143-5152. PMID: 29945991, PMCID: PMC6742772, DOI: 10.1158/1078-0432.ccr-18-0401.

Laird J, Ma J, Chau K, Chelius M, Shi W, Zhang Z, Lok B, Yahalom J. Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement. International Journal Of Radiation Oncology • Biology • Physics 2017, 100: 670-678. PMID: 29413280, PMCID: PMC5806138, DOI: 10.1016/j.ijrobp.2017.10.053.

Laird J, Lok B, Siu C, Cahlon O, Khan A, McCormick B, Powell S, Cody H, Wen H, Ho A, Braunstein L. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy. Annals Of Surgical Oncology 2017, 25: 154-163. PMID: 29094250, PMCID: PMC5827945, DOI: 10.1245/s10434-017-6209-4.

Sabari J, Lok B, Laird J, Poirier J, Rudin C. Unravelling the biology of SCLC: implications for therapy. Nature Reviews Clinical Oncology 2017, 14: 549-561. PMID: 28534531, PMCID: PMC5843484, DOI: 10.1038/nrclinonc.2017.71.